Antiretroviral drugs and pregnancy: Report of an alert on mitochodrial disease and nucleoside analogs;Antiretroviraux et grossesse: A propos d'une alerte sur pathologie mitochondriale et analogues nucleosidiques

Archives de Pediatrie

Volumn 7, Issue SUPPL. 2, 2000, Pages 407-408

  Bavoux, F ^a   Loubeyre Unique, C ^a   Blanche, S ^b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Service d'immunologie hématologie pédiatrique HÔpital Necker   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; RITONAVIR; SAQUINAVIR; STAVUDINE; VERTEX; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

CONFERENCE PAPER; CONGENITAL MALFORMATION; FETOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; MITOCHONDRIAL MYOPATHY; PREGNANCY COMPLICATION; RISK;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; MITOCHONDRIAL MYOPATHIES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; RISK; ZIDOVUDINE;

EID: 0034182501     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Delfraissy JF. Prise en charge thérapeutique des personnes infectées par le VIH. Paris : Médecine-Sciences Flammarion ; 1999.
2. Brinkman K, Ter Hofstede H, Burger DM, Smeitink JA. Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as a common pathways. Aids 1998 ; 12 : 1735-44.
3. Mayaux MJ, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, et al. Maternal factors associated with perinatal HIV-1 transmission: the french cohort study: seven years of follow-up observation. J Acquir Immune Defic Synd 1995 ; 8 : 188-94.
4. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistent mitochondrial dysfunction and perinatal exposure to anti-retroviral nucleoside analogues. Lancet 1999 ; 354 : 1084-9.
5. Diwan BA, Riggs CW, Logsdon D, Haines DC, Olivero OA, Rice JM, et al. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice. Toxicol Appl Pharmacol 1999 ; 161 : 82-99.
6. Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, et al. Incorporation of zidovudine into leukocyte DNA from HIV-1 positive adults and pregnant women, and cord blood from infants exposed in utero. Aids 1999 ; 13 : 919-25.
7. Scalfaro P, Chesaux JJ, Buchwalder PA, Biollaz J, Micheli JL. Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment. Intensive Care Med 1998 ; 24 : 247-50.
8. Grubert TA, Wintergertst U, Lutz-Friedrich R, Belohradsky BH, Rolinski B. Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy. Aids 1999 ; 13 : 1430-1.
9. Culnane M, Fowler MG, Lee SS, McSherry G, Brady M, O'Donnell K, et al. Lack of long-term effects of in utero exposure to zidovudine among unifected children born to HIV-infected women. JAMA 1999 ; 281 : 151-7.